B-cell lymphoma

miltenyi-biomedicine-reveals-key-results-from-daly-2-eu-trial

Miltenyi Biomedicine Reveals Key Results from DALY 2-EU Trial

Editorial 7 December, 2025

Miltenyi Biomedicine has announced significant findings from the pivotal DALY 2-EU trial, which assesses...

blood-cancer-drug-trial-boosts-survival-rates-to-90-

Blood Cancer Drug Trial Boosts Survival Rates to 90%

Editorial 18 August, 2025

A clinical trial conducted at the Calvary Mater Newcastle has dramatically increased survival rates...